Andere talen Evome Medical Technologies Inc.

Aandelen

BRTL

CA30053H1055

Beurs gesloten - Toronto S.E. Andere beurzen 21:41:33 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,095 ^CAD	0,00%		+5,56%	-54,76%

04/06	Transcript : Evome Medical Technologies Inc., Q2 2024 Sales/ Trading Statement Call, Jun 04, 2024
31/05	Evome Medical Technologies Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Evome Medical Technologies Announces Securities Issuances	14/06
Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2	03/06
Evome Medical Technologies : TECHNOLGIES, INC - Form 6-K	03/06
Evome Medical Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	31/05
Evome Medical Technologies Provides Biodex Operations Update	30/05
Evome Medical Technologies Inc. Receives an Initial Purchase Order from VMS	30/05
Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt	30/05
Evome Medical Technologies : FOREIGN PRIVATE ISSUER STATUS - Form 6-K	23/04
Evome Medical Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled	12/04
Canadian Investment Regulatory Organization Trade Resumption - EVMT	02/04
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt	02/04
Riddell, Inc. acquired Simbex, LLC from Evome Medical Technologies Inc. for $3.6 million.	02/04
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023	01/04
Evome Medical Engages ICP Securities Inc. for Automated Market Making Services	27/02
Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman	15/02
Evome Medical Technologies Inc. Announces Board Changes	15/02
Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024	08/02
Evome Medical Technologies Inc. Announces CFO Changes	02/02
Evome Medical Technologies Inc. Announces Change of Principal Accounting Officer	02/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Evome Medical Technologies Inc.

Aandelen

BRTL

CA30053H1055

Andere talen

Filters